XTL Biopharmaceutica (Israel) Risk Analysis And Volatility Evaluation

XTLB -- Israel Stock  

ILS 8.20  0.50  5.75%

Macroaxis considers XTL Biopharmaceutica unknown risk given 2 months investment horizon. XTL Biopharmaceuticals shows Sharpe Ratio of 0.035 which attests that XTL Biopharmaceuticals had 0.035% of return per unit of standard deviation over the last 2 months. Our philosophy towards determining volatility of a stock is to use all available market data together with stock specific technical indicators that cannot be diversified away. We have found twenty-one technical indicators for XTL Biopharmaceuticals which you can use to evaluate future volatility of the organization. Please utilize XTL Biopharmaceuticals Risk Adjusted Performance of 0.1692, Mean Deviation of 4.84 and Downside Deviation of 7.14 to validate if our risk estimates are consistent with your expectations.
Horizon     30 Days    Login   to change

XTL Biopharmaceutica Market Sensitivity

As returns on market increase, XTL Biopharmaceutica returns are expected to increase less than the market. However during bear market, the loss on holding XTL Biopharmaceutica will be expected to be smaller as well.
2 Months Beta |Analyze XTL Biopharmaceuticals Demand Trend
Check current 30 days XTL Biopharmaceutica correlation with market (DOW)
β = 0.288

XTL Biopharmaceutica Central Daily Price Deviation

XTL Biopharmaceuticals Technical Analysis

Transformation
We are not able to run technical analysis function on this symbol. We either do not have that equity or its historical data is not available at this time. Please try again later.

XTL Biopharmaceutica Projected Return Density Against Market

Assuming 30 trading days horizon, XTL Biopharmaceutica has beta of 0.288 . This means as returns on market go up, XTL Biopharmaceutica average returns are expected to increase less than the benchmark. However during bear market, the loss on holding XTL Biopharmaceuticals Ltd will be expected to be much smaller as well. Moreover, XTL Biopharmaceuticals Ltd has an alpha of 0.9644 implying that it can potentially generate 0.9644% excess return over DOW after adjusting for the inherited market risk (beta).
 Predicted Return Density 
      Returns 
Assuming 30 trading days horizon, the coefficient of variation of XTL Biopharmaceutica is 2853.62. The daily returns are destributed with a variance of 83.13 and standard deviation of 9.12. The mean deviation of XTL Biopharmaceuticals Ltd is currently at 5.59. For similar time horizon, the selected benchmark (DOW) has volatility of 1.38
α
Alpha over DOW
=0.96
β
Beta against DOW=0.29
σ
Overall volatility
=9.12
Ir
Information ratio =0.14

XTL Biopharmaceutica Return Volatility

XTL Biopharmaceuticals Ltd accepts 9.1176% volatility on return distribution over the 30 days horizon. DOW inherits 1.3055% risk (volatility on return distribution) over the 30 days horizon.
 Performance (%) 
      Timeline 

Market Risk Breakdown

XTL Biopharmaceutica Volatility Factors

60 Days Market Risk

Unknown risk

Chance of Distress in 24 months

Unknown Distress

60 Days Economic Sensitivity

Insignificant

Investment Outlook

XTL Biopharmaceutica Investment Opportunity

XTL Biopharmaceuticals Ltd has a volatility of 9.12 and is 6.96 times more volatile than DOW. 82% of all equities and portfolios are less risky than XTL Biopharmaceutica. Compared to the overall equity markets, volatility of historical daily returns of XTL Biopharmaceuticals Ltd is higher than 82 (%) of all global equities and portfolios over the last 30 days. Use XTL Biopharmaceuticals Ltd to protect against small markets fluctuations. The stock experiences very speculative upward sentiment.. Check odds of XTL Biopharmaceutica to be traded at S7.79 in 30 days. As returns on market increase, XTL Biopharmaceutica returns are expected to increase less than the market. However during bear market, the loss on holding XTL Biopharmaceutica will be expected to be smaller as well.

XTL Biopharmaceutica correlation with market

correlation synergy
Significant diversification
Overlapping area represents the amount of risk that can be diversified away by holding XTL Biopharmaceuticals Ltd and equity matching DJI index in the same portfolio.

XTL Biopharmaceutica Volatility Indicators

XTL Biopharmaceuticals Ltd Current Risk Indicators

See also Your Current Watchlist. Please also try ETF Directory module to find actively-traded exchange traded funds (etf) from around the world.
Search macroaxis.com